Southwest Oncology Group studies in bladder cancer (pages 2099–2108)
E. David Crawford, David P. Wood, Daniel P. Petrylak, Jennifer Scott, Charles A. Coltman Jr. and Derek Raghavan
Version of Record online: 1 APR 2003 | DOI: 10.1002/cncr.11286
The Southwest Oncology Group (SWOG) Genitourinary Cancer Committee has studied therapeutic interventions in patients with superficial, invasive, and metastatic bladder cancer over the past 15 years, including six Phase III randomized trials. In this report, the authors highlight SWOG accomplishments and discuss future strategies for patients with bladder cancer.